STK11 and colorectal cancer: Creation of isogenic pairs of cancer lines and their controls demonstrated that elimination of STK11/LKB1 expression in 2 primary cancers, human NSCLC and mouse colorectal cancer (CRC), conferred cachexia phenotypes when transplanted into immunocompromised and immunocompetent hosts, respectively.